David Baram - co-founder and CEO of Emendo Biotherapeutics

<p><strong id= "docs-internal-guid-e36ddfe6-7fff-9a3d-32cf-747ad1a5cf18">In this episode of Life Science Success, my guest is David Baram.  David Baram is the co-founder and CEO of Emendo Biotherapeutics. David has taken Emendo from the pre-seed stage through multiple financing rounds and a successful acquisition in 2020.</strong></p> <ul> <li>Don Davis, PhD, MBA interviews David Baram, PhD, CEO of Emendo Biotherapeautics</li> <li>Mendo is focused on developing gene editing therapies for rare and prevalent diseases, including cardiovascular diseases.</li> <li>They discuss the challenges of managing a company with different interests at play, including investors and patients.</li> <li>They touch on the potential of AI and the need for regulation and control.</li> <li>David shares his motivation and excitement in achieving his goals and seeing his inventions materialize.</li> </ul>